These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 7653432)
21. [Gastroesophageal reflux in the newborn]. Urrusti-Sanz J Gac Med Mex; 1995; 131(5-6):601-3. PubMed ID: 8768609 [No Abstract] [Full Text] [Related]
22. [Prokinetics in childhood]. Gottrand F Arch Pediatr; 2010 Jun; 17(6):737-8. PubMed ID: 20654867 [No Abstract] [Full Text] [Related]
23. Domperidone, a new dopamine antagonist. Champion MC; Hartnett M; Yen M CMAJ; 1986 Sep; 135(5):457-61. PubMed ID: 3527396 [TBL] [Abstract][Full Text] [Related]
24. [Results of the treatment of gastroesophageal reflux and peptic esophagitis using cisapride]. Carrasco Gandía S; Lama Moré R; Prieto Bozano G; Polanco Allue I An Esp Pediatr; 1990 Jun; 32(6):485-8. PubMed ID: 2221622 [TBL] [Abstract][Full Text] [Related]
25. Study with two prokinetics in functional dyspepsia and GORD: domperidone vs. cisapride. Halter F; Staub P; Hammer B; Guyot J; Miazza BM J Physiol Pharmacol; 1997 Jun; 48(2):185-92. PubMed ID: 9223023 [TBL] [Abstract][Full Text] [Related]
27. The diagnosis and management of gastro-oesophageal reflux in infants. Vandenplas Y; Salvatore S; Hauser B Early Hum Dev; 2005 Dec; 81(12):1011-24. PubMed ID: 16278060 [TBL] [Abstract][Full Text] [Related]
29. Effects of metoclopramide and bethanechol on delayed gastric emptying present in gastroesophageal reflux patients. McCallum RW; Fink SM; Lerner E; Berkowitz DM Gastroenterology; 1983 Jun; 84(6):1573-7. PubMed ID: 6132852 [TBL] [Abstract][Full Text] [Related]
30. Gastroesophageal reflux in infants and children. Jung AD Am Fam Physician; 2001 Dec; 64(11):1853-60. PubMed ID: 11764863 [TBL] [Abstract][Full Text] [Related]
31. [Cisapride: clinical experience in 1071 patients with non-ulcer dyspepsia or reflux symptoms]. Fehr HF Schweiz Med Wochenschr; 1991 Jun; 121(22):843-6. PubMed ID: 2063165 [TBL] [Abstract][Full Text] [Related]
32. Update on drugs for gastro-oesophageal reflux disease. Keady S Arch Dis Child Educ Pract Ed; 2007 Aug; 92(4):ep114-8. PubMed ID: 17644666 [No Abstract] [Full Text] [Related]
33. [A new granular effervescent 10-mg formulation of cisapride in the treatment of gastroesophageal reflux]. Grossi L; Di Felice F; Marzio L Clin Ter; 1993 Feb; 142(2):127-33. PubMed ID: 8472526 [TBL] [Abstract][Full Text] [Related]
34. Esophageal pH assessment of gastroesophageal reflux in 18 patients and the effect of two prokinetic agents: cisapride and metoclopramide. Rode H; Stunden RJ; Millar AJ; Cywes S J Pediatr Surg; 1987 Oct; 22(10):931-4. PubMed ID: 3681625 [TBL] [Abstract][Full Text] [Related]
35. The use of erythromycin as a gastrointestinal prokinetic agent in adult critical care: benefits versus risks. Hawkyard CV; Koerner RJ J Antimicrob Chemother; 2007 Mar; 59(3):347-58. PubMed ID: 17289772 [TBL] [Abstract][Full Text] [Related]
36. [Drug therapy of gastrointestinal motility disorders]. Jia B Zhonghua Nei Ke Za Zhi; 1995 Mar; 34(3):151-2. PubMed ID: 7648932 [No Abstract] [Full Text] [Related]
37. Use of prokinetic agents in special populations. Horn JR Am J Health Syst Pharm; 1996 Nov; 53(22 Suppl 3):S27-9. PubMed ID: 8931828 [TBL] [Abstract][Full Text] [Related]
38. Cisapride--more selective than metoclopramide. Drug Ther Bull; 1990 Nov; 28(23):89-90. PubMed ID: 2131232 [No Abstract] [Full Text] [Related]
40. [Effects of various prokinetic drugs on gastrointestinal transit times in patients with progressive systemic scleroderma]. Folwaczny C; Läritz M; Meurer M; Endres SP; König A; Schindlbeck N Z Gastroenterol; 1997 Oct; 35(10):905-12. PubMed ID: 9432812 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]